Drug Profile
Filgrastim biosimilar - Eurofarma
Alternative Names: Granulen; Granulocyte colony stimulating factor biosimilar - EurofarmaLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Eurofarma
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 09 Feb 2015 Launched for Neutropenia in Brazil (SC)